- ... yields clinical benefit. Patients with metastatic carcinoma with neuroendocrine differentiation. These patients are usually treated similarly to those ...
- ... growth factor 1. One or more markers of neuroendocrine differentiation can be found in approximately 75% of SCLC.[ ...
- ... ring adenocarcinoma. Scirrhous tumors. Neuroendocrine.[ 1 ] Tumors with neuroendocrine differentiation typically have a poorer prognosis than pure adenocarcinoma ...
- ... A study suggests that patients whose tumors exhibit neuroendocrine differentiation are more responsive to chemotherapy.[ 66 ] Immunotherapy Sipuleucel- ...
- ... neck) lymphadenopathy containing carcinoma and metastatic carcinoma with neuroendocrine differentiation. 2 Distribution parameters relate to requirements for TreeAge ...
- NLM Digital Collections - Antiandrogen therapies for nonmetastatic castration-resistant prostate cancer : effectiveness ...Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, October 4, 2018... Phase III Efficacy and placebo- mg) twice daily neuroendocrine differentiation or small cell evidence of metastasis or death ...
- ... with downregulation of important genes involved in the differentiation of neuroendocrine tissues.[ 49 ] The inheritance pattern of FPGL depends ...
- ... of neuroendocrine origin is seen in poorly differentiated neuroendocrine tumors of ... differentiation along a particular line. Often poorly differentiated tumors ...
- ... carcinoma. Medullary carcinoma. Undifferentiated carcinoma. Carcinoid (well-differentiated neuroendocrine neoplasm) Enterochromaffin-cell, serotonin-producing neoplasm. L-cell, ...
- ... the head of the pancreas cause biliary obstruction. Neuroendocrine tumors. 5%-17% of individuals with VHL develop ... gland [ Volkin et al 2012 ]. Pancreatic cysts and neuroendocrine tumors. Pancreatic cysts are common, rarely influence endocrine ...
95 results